RN7SL225P

Across TCGA pan-cancer cohorts, RN7SL225P RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated RN7SL225P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RN7SL225P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL225P expression acts as an unfavorable survival marker, although some lineages such as HNSC and STAD show a favorable association.

ACC, HNSC, and STAD are the cancer types where RN7SL225P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	III,IV	0.364	0.795	<.001	90	view →
HNSC	DFS	Tertile	II,III,IV	0.802	0.664	.011	75	view →
STAD	OS	Median	All	0.732	0.597	.007	32	view →
MESO	OS	Tertile	IV	0.077	0.592	.019	27	view →
LAML	DFS	Tertile	All	0.590	0.283	.005	22	view →
PCPG	OS	Tertile	All	0.323	1.000	<.001	21	view →
TGCT	DFS	Tertile	III,IV	0.505	1.000	.016	18	view →
OV	OS	Quartile	III,IV	0.389	0.265	.007	18	view →
THCA	DFS	Tertile	IV	0.462	0.908	.001	15	view →
BRCA	DFS	Tertile	III,IV	0.870	0.756	.020	12	view →
LGG	DFS	Tertile	All	0.468	0.371	.033	12	view →
KICH	OS	Quartile	All	0.917	1.000	.040	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

RN7SL225P–ACC (OS)

Open the ACC breakdown →